eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2021
vol. 38
 
Share:
Share:
abstract:
Original paper

Basophils priming in patients with chronic spontaneous urticaria

Krzysztof Gomułka
1
,
Marta Wrześniak
1
,
Wojciech Mędrala
1
,
Bernard Panaszek
1

1.
Department of Internal Medicine, Pneumology and Allergology, Medical University of Wroclaw, Wroclaw, Poland
Adv Dermatol Allergol 2021; XXXVIII (4): 608–610
Online publish date: 2021/09/17
View full text Get citation
 
Introduction
Basophils are one of the main target cells in chronic spontaneous urticaria (CSU). If cells present higher susceptibility to production and degranulation of pro-inflammatory factors, priming may be associated with severity of symptoms and therapy ineffectiveness. Aim: To evaluate the spontaneous state of increase in basophil activity and their priming profile in patients with CSU.

Material and methods
The study sample included 22 patients diagnosed with CSU and 20 healthy volunteers without either allergy symptoms or CSU. In this study, we evaluate the presence of CD63 and CD63+CD203c at basophils surface by flow cytometry test (basophil activation test – BAT).

Results
We found that the percentage of activated basophils was higher in patients with CSU than in the control group and this difference was statistically significant (p < 0.05).

Conclusions
Our results indicate a greater degree of basophils activation in patients with CSU in remission than in the control group; it might be useful for identification of patients with predominance of the autoimmune variant of CSU and typing patients responding (responders) and refractory (non-responders) to treatment with antihistamines.

keywords:

basophil, CD203c, CD63, chronic spontaneous urticaria

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.